IT1255269BITMI921253AITMI921253AIT1255269BIT 1255269 BIT1255269 BIT 1255269BIT MI921253 AITMI921253 AIT MI921253AIT MI921253 AITMI921253 AIT MI921253AIT 1255269 BIT1255269 BIT 1255269B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ITMI921253ApriorityCriticalpatent/IT1255269B/it
Publication of ITMI921253A0publicationCriticalpatent/ITMI921253A0/it
Publication of ITMI921253A1publicationCriticalpatent/ITMI921253A1/it
Application grantedgrantedCritical
Publication of IT1255269BpublicationCriticalpatent/IT1255269B/it
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Viene descritto l'uso di oxatomide e dei suoi sali non tossici e formaceuticamente accettabili quali principi ad attività antivirale e vengono descritte le composizioni farmaceutiche ad attività antivirale le quali contengono quantità terapeuticamente efficaci come antivirale di oxatomide e dei suoi sali non tossici, farmaceuticamente accettabili in miscela con adatti diluenti.
Use of 5'-deoxy-5'-methylthioadenosine,s-adenosylmethionine and their salts in the preparation of seborrhea-reducing pharmaceutical compositions,and the pharmaceutical compositions concerned
Compositions and the use of interleukin-2 and/or interferon-beta and tumour necrosis factor for combination therapy or in providing medicaments or formulations
Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
Use of 5'deoxy-5'methylthioadenosine, s-adenosylmethionine and their salts in the preparation of seborrhea-reducing pharmaceutical compositions, and the pharmaceutical compositions concerned